Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE
NCT07722780
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
500
Enrollment
INDUSTRY
Sponsor class
Conditions
Premature Ejaculation
Interventions
DRUG:
VV913 2mg Capsules
DRUG:
VV913 5mg Capsules
DRUG:
VV913 10mg Capsules
DRUG:
Placebo
Sponsor
Vigonvita Life Sciences